Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA’s REMS Drug Safety Program Sometimes Confusing To Patients, And A Barrier To Drug Access: Study Some patients believe the program is actually set up to benefit drug companies. January 24, 2022 Martha Garcia Add Your Comments A new study highlights the high levels of confusion surrounding a key drug safety program, indicating that most consumers believe the risk reduction efforts are intended to benefit drug manufacturers, not patients, or find information about potential drug side effects difficult to understand. The FDA’s Risk Evaluation and Mitigation Strategy (REMS) program was implemented to monitor medications with a high potential for serious side effects, authorizing the FDA to impose safety requirements on drugs with important risks. Requirements can include doctor certification, routine laboratory testing, or a requirement to use specific pharmacies. The REMS program requirements apply to specific prescription drugs and can include requirements for the patient to fulfill as well, as part of an effort to ensure that the benefits of using drugs with potentially severe side effects outweigh the risks. Researchers with Brigham and Women’s Hospital and Harvard Medical School conducted a survey of patients who encountered the REMS program, and found patients were often confused about what the program was for, what they were supposed to do, and who was benefitting from it. The findings were published January 20, in the journal JAMA Network Open. The researchers conducted a study of 63 participants in the REMS program. This included some patients who received one of four drugs subject to REMS program with Elements to Assure Safe Use (ETASU) requirements mandated by the FDA. It also included caregivers of patients taking those drugs. The study included phone interviews conducted between 2016 and 2017, focusing on four drugs: natalizumab, also known by the brand name Tysabri used to treat multiple sclerosis and Crohn’s disease; riociquat, known as Adempas used to treat pulmonary high blood pressure; sodium oxybate, known by the brand name Xyrem used to treat narcolepsy; and vigabatrin, known by brand name Sabril; an anticonvulsant used to treat seizures. Many patients and their caregivers reported difficulty understanding program educational materials and difficultly accessing medications easily. They also had concerns regarding data-sharing, with some participants saying the enrollment forms were overwhelming or vague. Patients reported that they knew obtaining the medication required meeting specific conditions, completing regular monitoring, or using centralized pharmacies. Yet, most participants said they did not know it was part of an FDA-mandated safety program. The study also indicated REMS requirements made some patients more likely to initiate treatment, but many reported difficulties accessing the necessary medication, including having to travel to certified prescribers or pharmacies. Some patients believed the REMS program was intended to help drug manufacturers or doctors, not patients. They also believed doctors were reimbursed for referring patients for enrollment, not as part of a mandatory program. Other patients thought the program was a way for a drug company to “cover its back if something went wrong,” such as patients suffering severe side effects. Learn More About Belviq Recall Lawsuits Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Belviq Recall Lawsuits Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Many patients said the program did not provide sufficient or clear information about the risks of the drugs or the reasons why the program exists to begin with. For example, progressive multifocal leukoencephalopathy is a side effect of taking Tysabri; but the information provided was too confusing or not clear enough for patients without a medical background. Furthermore, some patients said they were not sufficiently updated on new findings about their drug. For example, patients taking Tysabri were not informed when the program was significantly modified for that drug, like making vision testing voluntary instead of mandatory. “This qualitative study found that REMS programs with ETASU reassured patients and their caregivers about drug safety and helped support medication initiation,” the researchers concluded. “However, steps are needed to improve the quality of REMS educational materials, promote efficient medication access, and protect patient privacy.” The study’s findings come after the FDA halted its REMS program for the antipsychotic Clozapine last month, after patients reported difficulty accessing the drug and delays in treatment when healthcare professionals were not certified in the program by the specified due date. Additionally long call wait times have made it difficult for patients to access care. As a result, the FDA placed the REMS program for Clozapine on hold. Tags: Drug Side Effects, REMS, Tysabri More Belviq Lawsuit Stories Belviq Settlement Discussions Underway, as Cases Put on Hold May 12, 2022 Belviq Colon Cancer Lawsuit Cleared To Move Forward Over Diet Drug Maker’s Failure to Warn March 17, 2022 Lawsuit Alleges Link Between Rare Form of Brain Cancer and Belviq Diet Pills February 3, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Belviq Colon Cancer Lawsuit Cleared To Move Forward Over Diet Drug Maker’s Failure to Warn March 17, 2022
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)